Navigation Links
American Laser Centers Names Bill Van Huis as Chief Revenue Officer
Date:2/25/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... HR Consulting firm CPEhr, and Ju...d a Job Shadow Day for 30 high-students from Downt...d HR topics such as labor law, interviewing techni...les, Calif. (PRWEB) July 24, 2008 -- Los Angeles ... a non-profit organization, hosted a Job Shadow Da...
(Date:7/24/2008)... A cleanroom manufacturing compan...ule cleanrooms. The feature is a utility panel wh...d enhance the cleanroom appearance. , ...08 -- Gerbig Engineering, a designer, fabricator a... that they are now offering a utility panel for in...
(Date:7/24/2008)...ON, July 24 /PRNewswire-FirstCall/ --, Key Highli... of expectations and is now,raising targets for th...oup,revenues(1) of GBP492m up 6%, bringing Group o...ar. Misys is executing on its strategy and enterin...ding a platform for growth., To view the Multimed...
(Date:7/23/2008)... Ganey reports need for better physician-administr... nearly 28,000 physicians, SOUTH BEND, Ind., July...ospital Check-Up Report: Physician Perspectives on...be a gap in the physician-administration,relations...rs to be more,responsive to the ideas and needs of...
Breaking Medicine News(10 mins):Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 2Health News:CPEhr and Junior Achievement Prepare High-School Students For the Workforce 3Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Authoritative Report on Physician Perspectives Released Today 2
...rganization (WHO) the leading cause of maternal de...//, Africa and Latin America. Statistics show tha...omplications and over half a million die every yea...s department of reproductive health and research s...
...ril issue of Radiology says that ultrasound is the...women and also assess// the effectiveness of chemo...Center in Houston have just finished a study where... been diagnosed as well as treated for breast canc...
...eveloped in the US are at an advanced stage but it...he public, says an expert involved in the project....rt. There are large numbers of people involved and...esting methods. We are on the way but it will be a...
...haracterised by extreme and irrational fear of sim...not know exactly what causes this. // To overcome...hich is still in the trial stage. The remedy deve... team contains a human hormone called cortisol, wh...
Other Medicine News:Health News:Ultrasound Can Detect Breast Cancer in Pregnant Women 2Health News:HIV Vaccine Field Trials In Advanced Stage 2
(Date:7/23/2008)... Study results pending publication in July print e... available on Web, INDIANAPOLIS, July 23 /PRNewsw...evaluating the use of N-terminal pro-B-type natriu...alue of NT-proBNP for risk,stratification in predi...V-AE) in patients treated with non-steroidal anti-...
(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have Grea...TS, Ill., July 23 /PRNewswire-USNewswire/ -- Fat r...ugh liposuction was found to be,an excellent sourc...ons,than other areas of the body, reports a Brazil...tive Surgery(R), the official medical journal of t...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-FirstCal...ate yesterday, the Board of Progen,Pharmaceuticals...that it,had discontinued the PI-88 phase 3 study i...ection to develop its existing portfolio of compou...additional compounds and,opportunities through Mer...
(Date:7/22/2008)... FDA Meeting to Discuss Development Plan Comple...swire-FirstCall/ -- Amarin Corporation,plc (NASDAQ...y met with,officials at the U.S. Food and Drug Adm...o develop AMR101 for the treatment of,hypertriglyc... is,proceeding to Phase 3 with AMR101 in hypertrig...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Compendia Bioscience Announces the Release and Availability of Oncomine 28TM 29 Research Premium Edition 1289 1Compendia Bioscience Announces the Release and Availability of Oncomine 28TM 29 Research Premium Edition 1289 2Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice 1286 1Pioneer in Reproductive Medicine Opens The Countrys First Comprehensive Fertility Practice 1286 22007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies 1283 12007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies 1283 22007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies 1283 3Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 1Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 2Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 3Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 4Data from Three Clinical Trials for Perforomist 28TM 29 Inhalation Solution to be Presented at CHEST 2007 on October 24 2007 531 5
...DGE, Mass., April 13, 2007 /PRNewswire/ -- Mersana...hat results of,preclinical studies with its lead p...wo posters at the 2007 Annual Meeting of the,Ameri...lace April,14-18th in Los Angeles, CA. Full text o...ebsite at <a target="_blank" href=,"http://www.aac...
...GE, Mass.--(BUSINESS WIRE)--Apr 13, 2007 - Biogen ...year data presented at the,Academy of Managed Care...VONEX(R) (Interferon beta-1a) is a cost-effective ...o other interferon beta,treatments. Using a compre...e results of the research concluded that patients ...
Other Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 2New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 3
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: